Vishal Gupta, MD
Gastroenterology · Orange City, FLNPI 1255449179
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $16,800 of the $24,697 with a category attached, or 68.0%. Medtronic accounts for 71.7% of it on its own, with 41 other manufacturers making up the rest. 2025 is the largest year on record at $11,495, more than ten times the $857 reported in 2019. Among gastroenterology clinicians in FL with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 392 payments — averaging $63.00 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$18K
- AbbVie$2K
- Phathom Pharmaceuticals, Inc.$658
- Johnson & Johnson$526
- Takeda Pharmaceuticals U.S.A., Inc.$407
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$280
- plus $3K from 36 others
Across 175 payments — averaging $4980.62 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Genentech, Inc.$640K
- Bausch Health US, LLC$195K
- Takeda Pharmaceuticals U.S.A., Inc.$18K
- Regeneron$14K
- Bristol Myers Squibb$3K
- Redhill Biopharma Inc.$1K
What the payments were for
- Consulting fees$180%
- Speaking & faculty fees$16,80068%
- Food & beverage$7,78332%
- Education$950%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- INTERSTIM$17,037
- VOQUEZNA$288
- EndoClot PHS$141
- OMVOH$121
How this compares
$24,697 in reported general payments places this provider in the 90th percentile of 1,388 gastroenterology providers in Florida.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| LinzessLinaclotide | 18 | $22,678 |
| MovantikNaloxegol Oxalate | 20 | $9,936 |
| Sod Sulf-Potass Sulf-Mag SulfSodium, Potassium,mag Sulfates | 97 | $5,721 |
| Omeprazole | 230 | $3,533 |
| ClenpiqSod Picosulf/Mag Ox/Citric Ac | 19 | $3,202 |
| Pantoprazole Sodium | 178 | $2,292 |
| Colestipol Hcl | 21 | $1,421 |
| PlenvuPeg3350/Sod Sul/Nacl/Kcl/Asb/C | 11 | $1,375 |
| Sucralfate | 22 | $1,128 |
| Famotidine | 50 | $795 |
| Diphenoxylate-AtropineDiphenoxylate Hcl/Atropine | 20 | $754 |
| Gavilyte-GPeg3350/Sod Sulf,bicarb,cl/Kcl | 41 | $704 |
| Bethanechol Chloride | 15 | $575 |
| Ondansetron OdtOndansetron | 15 | $546 |
| Esomeprazole Magnesium | 21 | $375 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| AbbVieLinzess | $2,131 | $22,67818 claims |
| Redhill Biopharma Inc.Movantik | $54 | $9,93620 claims |
| Ferring Pharmaceuticals Inc.Clenpiq | $61 | $3,20219 claims |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLCPlenvu | $280 | $1,37511 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 1,388 gastroenterology providers in Florida.
Other gastroenterology in Orange City
- Samuel GidayOrlando$2M
- Lukasz KwapiszMiami$1.2M
- Jennifer Seminerio-DiehlOrlando$1.1M
- Udayakumar NavaneethanSaint Petersburg$1.1M
- Ronen AraiCoral Springs$1.1M
- Charles SninskyGainesville$983K
- Peter DraganovGainesville$832K
- Arin NewmanMiami Beach$716K
- Joanna LopezMiami$670K
- Jose NietoSebring$573K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.